1,580 material Form 8-K filings that 1,317 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Mobility Global Inc. became an independent, publicly traded company on July 1, 2026, after S&P Global distributed 100% of its shares to S&P Global stockholders. The separation matters to shareholders because S&P Global retains no ownership in Mobility Global, and the company now operates under agreements with S&P Global covering taxes, transition services, and employees.
Distribution ratio: one Mobility Global share for every S&P Global share held at close of business on June 15, 2026
Separation effective 12:01 a.m. New York City time on July 1, 2026; shares trade on the NYSE under MBGL
Transition services from S&P Global may run up to 18 months; Mobility Global may terminate them on prior written notice
Tax Matters Agreement restricts certain actions for two years after the Distribution Date to preserve tax-free treatment
S&P Global completed the separation of its Mobility division on July 1, 2026, distributing 100% of Mobility Global Inc. common stock to S&P Global stockholders. S&P Global retains no ownership interest in Mobility Global, which is now an independent company listed on the New York Stock Exchange under MBGL. The filing sets out agreements covering the separation, taxes, transition services and employees, and the company plans to issue recast 2025 and first-quarter 2026 financial information on July 6, 2026.
Distribution Date was July 1, 2026, effective at 12:01 a.m. New York City time.
Stockholders of record on June 15, 2026 received one share of Mobility Global common stock for every S&P Global share held.
Transition services from S&P Global to Mobility Global are generally available for up to 18 months after the Distribution.
Mobility Global faces restrictions on certain actions for two years after the Distribution Date to preserve tax-free treatment.
On June 30, 2026, Jackson Financial entered a revolving credit agreement with aggregate commitments of $1.25 billion, led by Wells Fargo as administrative agent. The new agreement replaces the company's $1 billion 2023 credit facility, which was scheduled to terminate in February 2028, and the filing describes its covenants as substantially similar to that earlier agreement.
Aggregate commitments of $1.25 billion, with a $500 million sub-limit for letters of credit and a possible increase of up to $500 million on request
Replaces the $1 billion credit agreement dated February 24, 2023, which was scheduled to terminate in February 2028
Commitments terminate June 30, 2031, with two one-year extension options subject to required bank approval
Borrowings are unsecured, priced at Term SOFR plus 1.125% to 1.875% or Base Rate plus 0.125% to 0.875%, based on the company's senior debt ratings
Avalyn Pharma entered a First Amendment to its sublease with CRISPR Therapeutics, effective June 29, 2026, expanding the Boston premises from about 8,774 to about 13,708 rentable square feet. The amendment raises the company's future minimum lease payments by approximately $924,000 over the remaining lease term, a modest commitment that shareholders may want to note.
Effective date: June 29, 2026; the sublease covers 105 West First Street, Boston, Massachusetts
Premises expand from approximately 8,774 to approximately 13,708 rentable square feet
Future minimum lease payments increase by approximately $924,000 over the remaining lease term
All other terms of the original August 29, 2025 sublease remain in effect
Reinsurance Group of America appointed Maurice Tulloch, former Group CEO of Aviva, to its board effective July 1, 2026, increasing the board to thirteen directors. The company says the board has determined he is independent under NYSE listing standards, and he has not yet been named to any board committee.
Board appointment effective July 1, 2026, with a term ending at the 2027 annual meeting of shareholders
Board size increases to thirteen directors
Non-employee director pay will be prorated from a $125,000 annual retainer and a $165,000 annual stock grant
Tulloch has not yet been named to any board committee
At its June 26, 2026 annual meeting, Ambarella shareholders approved an amended and restated 2021 Equity Incentive Plan, along with the election of three Class II directors and the ratification of PricewaterhouseCoopers LLP as auditor for the fiscal year ending January 31, 2027. The plan vote was closer than the other items, with 22,122,462 shares voting for and 10,481,483 against, so the change to equity awards drew notable opposition.
Plan approval: 22,122,462 for, 10,481,483 against, 53,190 abstentions, with 5,199,177 broker non-votes
Board elections: Gregory M. Bryant, D. Jeffrey Richardson and Elizabeth M. Schwarting elected as Class II directors, serving until the 2029 annual meeting
Auditor: PricewaterhouseCoopers LLP ratified for fiscal year ending January 31, 2027 (37,426,967 for, 407,966 against)
Shares represented: 37,856,312 of 43,861,484 outstanding shares, about 86.31%, as of the May 5, 2026 record date
Whirlpool announced on July 1, 2026 that it will close its Supsa manufacturing facility in Apodaca, Mexico, by the second quarter of 2027, moving production to its Ramos Arizpe, Mexico plant and across its supply chain. The company estimates $165 million in total restructuring costs, with about $70 million expected to be cash expenditures, so shareholders face a large charge now while the filing does not quantify the expected savings.
Supsa facility in Apodaca, Mexico to close by the second quarter of 2027, with production shifted to Ramos Arizpe, Mexico
Estimated total restructuring costs of $165 million: up to $95 million asset impairment, $30 million employee-related, and $40 million other
About $100 million of the $165 million expected in 2026; about $70 million total cash expenditures, with $15 million expected in 2026
Actions expected to be substantially complete in 2027
Hims & Hers subsidiaries XeCare LLC and Apostrophe Pharmacy LLC entered a Master Receivables Purchase Agreement with JPMorgan Chase Bank on July 1, 2026, allowing them to sell eligible receivables for cash, subject to a $400 million facility limit. The company also agreed to guarantee the sellers' performance under the agreement, though not the collectability of the receivables, and amended its credit agreement to permit the arrangement.
Facility limit for eligible receivables is $400 million, with an initial term of 364 days that may be extended.
The company guarantees the sellers' performance under the agreement but not receivable collectability or seller creditworthiness.
Amendment No. 4 to the Revolving Credit and Guaranty Agreement, dated June 26, 2026, adds a $400 million debt basket for this arrangement.
The filing does not disclose the purchase discount or any financial results tied to the arrangement.
Compass Therapeutics furnished an updated corporate presentation dated July 2026 that includes data from its COMPANION-002 study of tovecimig plus paclitaxel in biliary tract cancer. The study met its primary endpoint of overall response rate (18.0% vs 5.3%) and showed a longer median progression-free survival (4.7 vs 2.6 months), but overall survival was not significantly different (8.9 vs 9.4 months) because of crossover.
Primary endpoint overall response rate was 18.0% for tovecimig plus paclitaxel vs 5.3% for paclitaxel alone (p=0.0228)
Median progression-free survival was 4.7 vs 2.6 months (HR=0.44, p<0.0001); median overall survival was 8.9 vs 9.4 months (HR=1.05, p=0.78)
Company plans an FDA meeting in Q3 2026 and a BLA filing in Q4 2026, with potential approval in 2027
Company reported $195 million in cash and marketable securities at Q1 2026, with runway into 2028
Apogee Enterprises completed its acquisition of Keller Companies, Inc., including Kalwall Corporation and Structures Unlimited, on July 1, 2026. The company paid $105 million in cash at closing, with up to an additional $10 million of contingent consideration tied to the acquired businesses' future performance. The deal was funded with available cash and borrowings under the existing revolving credit facility.
Base purchase price of $105 million paid at closing, subject to customary post-closing adjustments
Up to $10 million of additional contingent consideration based on future financial performance of the acquired companies
Funded with available cash and borrowings under the existing revolving credit facility
Merger Agreement dated May 27, 2026 was previously reported in an 8-K filed May 28, 2026
Aon's board approved an additional $7.5 billion share repurchase authorization on June 26, 2026, on top of about $0.8 billion remaining under the existing program as of March 31, 2026. At the same meeting, shareholders did not approve the advisory vote on executive compensation, while all 13 director nominees were elected.
Board approved an additional $7.5 billion repurchase authorization on June 26, 2026; the program does not obligate Aon to buy any particular amount of shares.
Existing program had about $0.8 billion of remaining authorization as of March 31, 2026.
Advisory say-on-pay vote failed: 69,888,299 for, 110,798,636 against, 1,112,848 abstain.
All 13 director nominees were elected at the June 26, 2026 Annual Meeting, including Lester B. Knight and Gregory C. Case.
Nasdaq, Inc. entered into an amended and restated credit agreement on June 30, 2026, providing a $1.5 billion senior unsecured five-year revolving credit facility that replaces its existing 2022 credit agreement as amended. As of July 1, 2026, no loans were outstanding, and the facility matures on June 30, 2031, so the filing mainly refinances existing borrowing capacity rather than adding new debt today.
On June 25, 2026, Six Flags amended the employment agreement of Chief Operating Officer Tim Fisher. The amendment sets the agreement's term to expire on December 15, 2026, and extends certain benefits through that date to retain him. Mr. Fisher agreed not to receive a 2026 annual equity grant or retention bonus under the agreement.
Amendment entered into June 25, 2026, covering the employment agreement of COO Tim Fisher
Agreement term will expire December 15, 2026
Certain benefits extended through December 15, 2026 to retain Mr. Fisher
Mr. Fisher will not receive a 2026 annual equity grant or retention bonus payment under the agreement
NHC completed its purchase of the real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors for $560 million, ending a lease arrangement under which NHC had operated these facilities since a 1991 master lease. The company said it expects the ownership to be accretive to earnings and cash flow, but the filing gives no figures for that expectation. The deal was funded with $530 million of new borrowings, which adds to NHC's debt.
Purchase price of $560 million for real estate of 35 facilities (32 skilled nursing, 3 independent living), located in seven states
Drew the entire $475 million senior unsecured term loan and $55 million under the revolving credit facility on the closing date
Revolving credit facility increased from $50 million to $75 million under a First Amendment dated June 29, 2026; prior $50 million facility terminated with no outstanding borrowings
Four Florida skilled nursing facilities remain subject to a third-party operator's lease, which NHC has assumed under a subsidiary
Kohl's amended its revolving credit facility with Wells Fargo Bank as agent on June 30, 2026, extending the maturity by five years to June 30, 2031. The amendment also changes borrowing costs and borrowing base terms, including a new in-transit inventory basket capped at 15% of the borrowing base.
Maturity extended five years from the effective date of the amendment to June 30, 2031
Applicable Margin now ranges from 0.25% to 0.50% for Base Rate Loans and 1.25% to 1.50% for SOFR Loans, using a single 50% availability breakpoint
Removed the prior 0.10% credit spread adjustment from Term SOFR; in-transit inventory may count up to 15% of the borrowing base
Williams Companies (NYSE: WMB) appointed Lloyd W. "Billy" Helms, Jr. and Robb E. Turner as independent directors effective July 1, 2026, increasing the board from ten to twelve members. The company says both bring extensive energy industry experience, and the board will have 11 independent members out of 12.
Helms, former president of EOG Resources, Inc., will serve on the Compensation and Management Development Committee and the Environmental, Health and Safety Committee.
Turner, chairman of The Madava Group and Revenant Energy and co-founder of ArcLight Capital Partners, will serve on the Audit Committee and the Governance and Sustainability Committee.
Each new non-employee director will receive a $130,000 annual cash retainer and a $200,000 annual equity retainer in restricted stock units, with the 2026 equity awards subject to a mandatory one-year deferral.
Culp reported fourth-quarter fiscal 2026 net sales of $51.6 million, up 5.8% from a year earlier, but its net loss widened slightly to $2.2 million, or $0.18 per diluted share, from $2.1 million, or $0.17 per share. For the full year ended May 3, 2026, sales fell 4.6% to $203.5 million while the net loss narrowed to $10.2 million, or $0.81 per share, from $19.1 million. The company expects to recover about $7.0 million in IEEPA tariff refunds in the first quarter of fiscal 2027, which it says should reduce net debt to about $5.0 million at that quarter-end.
Q4 net sales $51.6 million, up 5.8% from $48.8 million a year earlier; gross profit fell to $6.8 million from $7.7 million
Q4 net loss $2.2 million, or $0.18 per diluted share, versus $2.1 million, or $0.17, in the prior-year quarter
Full-year net loss $10.2 million, or $0.81 per share, versus $19.1 million, or $1.53, in fiscal 2025
Outlook: about $7.0 million in IEEPA tariff refunds expected in Q1 fiscal 2027; net debt expected near $5.0 million at quarter-end
National Health Investors completed the sale of 35 facilities, including 32 skilled nursing facilities and three independent living facilities, to subsidiaries of National HealthCare Corporation (NHC) for a total purchase price of $560 million, effective July 1, 2026. The Master Lease was terminated for all facilities except four Florida skilled nursing facilities, which were assigned to an NHC subsidiary. NHC is a shareholder of the company, and a special committee of independent directors unanimously approved the transaction, but the filing does not state the effect on future rental income or earnings.
Transaction closed July 1, 2026 at a total purchase price of $560 million for the property
Sold 35 facilities: 32 skilled nursing facilities and three independent living facilities
Master Lease terminated for all facilities except four Florida skilled nursing facilities, assigned to an NHC subsidiary
NHC owned 1,630,642 shares of the company's common stock as of December 31, 2025; a special committee of independent directors unanimously approved the deal
Apollo Global Management said preliminary estimates show alternative net investment income of approximately $350 million (pre-tax) for the quarter ended June 30, 2026, an estimated 9% annualized return on alternative net investments. The figures are unaudited and not yet final, and the full second-quarter earnings release is scheduled for August 4, 2026, so shareholders should wait for the final results before relying on these numbers.
Estimated alternative net investment income: approximately $350 million pre-tax for Q2 2026
Estimated annualized return on alternative net investments: 9%
Estimated pooled vehicle return of 10% and other alternative investments return of 6%, both for Q2 2026
Full Q2 earnings release and financial supplement scheduled for August 4, 2026; figures are unaudited and may change materially
On June 29, 2026, Avis Budget Group and subsidiaries Avis Budget Holdings, LLC and Avis Budget Car Rental, LLC entered an Eleventh Amendment to their Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment replaces the existing $2 billion revolving facility with a new $2 billion facility and adds a new $200 million revolving facility, both with springing maturities tied to other debt and legal settlement proceeds. The filing does not state pricing, drawn balances or the prior maturity date.
New $2 billion revolving facility (2031 Revolving Facility) matures June 29, 2031, with a springing maturity 90 days before certain long-term debt maturities if that debt exceeds $300 million
New $200 million revolving facility (2028 Revolving Facility) matures June 29, 2028
Amendment closed June 29, 2026; the 8-K was filed July 1, 2026 with the agreement attached as Exhibit 10.1
On June 29, 2026, Mama's Creations agreed to sell 5,555,556 shares of common stock at $18.00 each, with gross proceeds of approximately $100 million before fees. The offering was completed July 1, 2026, with net proceeds of approximately $94.0 million, which the company intends to use for working capital, general corporate purposes and possibly acquisitions with no current agreements. New shares dilute existing holders, and the company's filing also updates risk factors on integrating the Crown I Carve Out Business.
5,555,556 shares sold at $18.00 per share; gross proceeds of approximately $100 million before fees.
Underwriters have a 30-day option to buy up to 833,333 more shares; full exercise would bring gross proceeds to about $115 million.
Offering completed July 1, 2026; net proceeds of approximately $94.0 million for working capital and general corporate purposes.
Risk factor update on integrating the Crown I Carve Out Business, acquired September 2, 2025.
American Eagle Outfitters said Michael Mathias will step down as Executive Vice President and Chief Financial Officer and become a non-officer Strategic Advisor to CEO Jay Schottenstein, effective August 3, 2026. Ravi Thanawala, formerly CFO and President, North America at Papa John's International, will succeed him as CFO on the same date. The company also reaffirmed its second quarter and full-year fiscal 2026 guidance, originally given May 28, 2026.
Ravi Thanawala becomes Executive Vice President and Chief Financial Officer effective August 3, 2026, succeeding Michael Mathias
Mathias serves as Strategic Advisor to the CEO through July 30, 2027, and will not be eligible for any fiscal 2027 annual bonus or new equity awards
Thanawala's offer letter provides a $1,000,000 base salary, a target bonus of 100% of eligible earnings, and a $1,000,000 sign-on cash bonus
The company reaffirmed second quarter and full-year fiscal 2026 guidance, first provided on May 28, 2026
On July 1, 2026, Qnity Electronics entered into Repricing Amendment No. 1 to its October 31, 2025 credit agreement with JPMorgan Chase Bank, N.A. The amendment lowers the interest margin on all $2,338,250,000 of outstanding term loans, and the company says other loan terms are not materially changed. Lower borrowing costs can help free cash for shareholders, though the filing does not quantify the savings.
All $2,338,250,000 of term loans outstanding before July 1, 2026 were repriced.
Term SOFR margin falls from 2.00% to 1.75%; Base Rate Loan margin falls from 1.00% to 0.75%.
A 1.00% premium applies to certain repricing-related prepayments or amendments through six months after the closing date.
Other terms, including maturity, security and covenants, are described as materially unchanged.
AMD's board approved higher base salaries for five executive team members, effective July 1, 2026, and set long-term equity awards to be granted on August 15, 2026. CEO Lisa Su's salary rises from $1,323,000 to $1,375,000, and her $36 million target award will be mostly performance-based, so the final share count depends on future shareholder return and earnings targets.
Base salaries rise effective July 1, 2026; Lisa Su goes from $1,323,000 to $1,375,000 and Jean Hu from $800,000 to $850,000
Long-term awards with target values of $36 million for Su, $9 million for Hu, $10 million for Mark Papermaster, $7.5 million for Darren Grasby and $8 million for Forrest Norrod, granted August 15, 2026
Su's award is 75% performance-based restricted stock units (PRSUs) and 25% time-based RSUs; the others receive 60% PRSUs and 40% RSUs
PRSUs can pay out from 0% to 250% of target, based on relative total shareholder return over August 15, 2026 to August 15, 2029 and fiscal 2028 non-GAAP EPS against the fiscal 2026 target
Michael Goettler resigned from the Bausch Health Board of Directors, effective June 30, 2026, to take up the role of President and Chief Executive Officer of Knoa Pharma LLC. The company said his resignation did not result from any disagreement over its operations, policies or practices. The filing contains no financial figures, and the change affects board composition only.
Goettler notified the company of his resignation on June 26, 2026; it takes effect June 30, 2026.
He is joining Knoa Pharma LLC as President and Chief Executive Officer.
The company states the resignation was not due to any disagreement on its operations, policies or practices.
Board Chairperson John A. Paulson thanked Goettler for his service in the July 1, 2026 press release.
Viatris entered into an amended and restated term loan credit agreement on July 1, 2026, providing a ¥40 billion senior unsecured term loan facility with Mizuho Bank, Ltd. as administrative agent. The filing says proceeds will be used in part to repay the prior ¥40 billion unsecured term loan dated July 1, 2021, so the facility replaces existing debt of the same stated amount rather than adding a new borrowing of that size.
Facility amount is ¥40 billion, the same principal as the prior term loan dated July 1, 2021, which the proceeds are partly used to repay.
Interest is set at the TIBO Rate plus 1.10% per annum initially, with the margin able to change based on Viatris's credit ratings from S&P Global Ratings, Moody's and Fitch.
Borrowings are due three years from the July 1, 2026 Closing Date and include a leverage ratio covenant of no greater than 3.75 to 1.00 at each fiscal quarter end.
Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. guarantee the facility as of the Closing Date.
Greenbrier reported fiscal third-quarter revenue of $576.5 million, down from $842.7 million a year earlier, and net earnings attributable to Greenbrier of $18.9 million, or $0.60 per diluted share, compared with $60.1 million a year earlier. The company narrowed its fiscal 2026 EPS guidance to $3.00 to $3.15 from $3.00 to $3.50 and lowered its aggregate gross margin guidance to 13.8% to 14.2%, which weighs on shareholders' expected earnings.
Q3 revenue of $576.5 million versus $842.7 million in the year-earlier quarter and $587.5 million in the prior quarter
Diluted EPS of $0.60 versus $1.86 a year earlier and $0.47 in the prior quarter
FY26 EPS guidance lowered to $3.00 to $3.15 from $3.00 to $3.50; aggregate gross margin guidance cut to 13.8% to 14.2% from 14.8% to 15.2%; revenue guidance unchanged at $2.4 billion to $2.5 billion
Quarterly dividend of $0.34 per share, payable August 6, 2026, to shareholders of record as of July 16, 2026
AppFolio announced that long-time chairman Andreas von Blottnitz and director Janet Kerr retired from the board effective June 29, 2026, and that two new independent directors, Diya Jolly and Michael Yang, were elected to fill the vacancies. The board also named CEO Shane Trigg as chairman, created a Lead Independent Director role held by Winifred Webb, and revised non-employee director pay. The filing does not discuss financial results, and the changes are governance updates rather than a financial event.
Andreas von Blottnitz (director since 2007) and Janet Kerr (director since 2015) retired effective June 29, 2026; the company says neither retirement involved a disagreement.
Shane Trigg, President and CEO, was appointed Chairman of the Board, succeeding Mr. von Blottnitz; he receives no separate pay for the role.
Winifred Webb was appointed Lead Independent Director; the annual cash retainer for that role is $40,000.
Non-employee director annual equity award rises to $200,000 from $150,000; Committee Chair retainer falls to $40,000 from $50,000.
Employers Holdings, Inc. (NYSE: EIG) said Stephanie C. Bush was elected to its board on June 25, 2026, with her term starting July 1, 2026, and the board size increased to nine directors. Bush, a former Hartford executive who retired in March 2024, has not yet been assigned to any board committees, and the filing contains no financial results.
Bush was elected to the board on June 25, 2026; her term began July 1, 2026.
The board size increased to nine directors.
Bush retired from The Hartford in March 2024, where she was Executive Vice President and Head of Small Commercial and Personal Lines Insurance.
No committee assignments yet; the company plans to file an 8-K amendment once the board sets them.
National Health Investors entered into a Change in Control Severance Agreement with CFO Todd Siefert, effective July 1, 2026. The agreement sets severance payments and benefits if he is terminated without Cause or resigns for Good Reason within two years after a change in control.
Agreement dated and effective July 1, 2026, with Todd Siefert, who signed the filing as Chief Financial Officer
Lump sum payment of 2.0 times the average of base salary and bonus over the most recent two calendar years, plus a pro-rated target or earned bonus
18 months of COBRA coverage and accelerated vesting of time-based equity awards; non-compete and non-solicit run 12 months after severance is paid
Astrana Health said its Chief Accounting Officer and principal accounting officer, Glenn Sobotka, will retire effective August 7, 2026, with the company saying the decision does not reflect any disagreement on operations, policies, or practices. John Vong, previously the company's Group Vice President, Accounting, will succeed him as principal accounting officer on that date. The change is administrative in nature and does not alter reported financial results.
Glenn Sobotka retires as Chief Accounting Officer effective August 7, 2026; the agreement was reached June 25, 2026
John Vong becomes Senior Vice President, Accounting effective July 1, 2026, and principal accounting officer on August 7, 2026
Vong's annual base salary rises to $320,000 effective July 1, 2026; his 2026 target bonus percentage is unchanged
On June 30, 2026, Evergy and three utility subsidiaries entered a credit agreement allowing up to $3.5 billion in aggregate borrowings, maturing June 30, 2031. The same day, they terminated a $2.5 billion credit agreement due August 31, 2028 and a $1 billion delayed draw term loan due August 10, 2026, with no early termination penalties. The filing does not state borrowing costs, so the financial effect for shareholders is not quantified beyond the facility size and terms.
Credit facility allows maximum borrowings of up to $3.5 billion, with sublimits of $200 million for letters of credit and $250 million for swingline loans
Matures June 30, 2031; borrowers may extend on up to two occasions for one-year terms and may increase commitments by up to $1 billion
Terminated the $2.5 billion credit agreement dated August 31, 2021 and the $1 billion delayed draw term loan dated May 5, 2026, with no early termination penalties
Marchex completed its acquisition of 100% of Archenia, Inc., a performance-based marketing technology company, on July 1, 2026. Stockholders approved the deal at a special meeting on the same day, with about 99.9% approval under both the simple majority and majority-of-the-minority votes. The company issued $10 million in 6% convertible notes to the sellers, and may issue additional shares if Archenia meets revenue, Adjusted EBITDA and integration targets.
Acquisition closed July 1, 2026; Archenia is a performance-based marketing technology company.
Company issued $10 million of convertible promissory notes bearing 6% interest, payable in three equal tranches at 12, 18 and 24 months after closing.
Notes convert into Class B common stock at $1.80 per share.
Earn-out of 2 million Class B shares for each of the first two 12-month periods, subject to revenue or Adjusted EBITDA growth and integration or customer retention targets.
Resideo's Board formally approved the planned spin-off of its ADI Global Distribution business, with a distribution date of August 3, 2026. Resideo shareholders are expected to receive one ADI share for every two Resideo shares held at the July 20 record date. To help finance the spin-off, ADI completed a $400 million senior notes offering and entered into a $600 million term loan and $500 million revolving credit facility.
Record date July 20, 2026; distribution date August 3, 2026, at 5:00 p.m. ET
Distribution ratio of one ADI share for every two Resideo shares held at the record date
ADI expected to trade on the NYSE as ADIG starting August 4, 2026; Resideo continues to trade as REZI
$400 million 7.125% senior notes due July 15, 2034, closed June 30, 2026; $600 million term loan and $500 million revolver entered July 1, 2026
Rigel Pharmaceuticals appointed director Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer effective July 1, 2026, and she resigned from the Board at the same time. The filing also says Lisa Rojkjaer, M.D. left the Chief Medical Officer role and the company effective June 25, 2026, so the change is a leadership transition in a key clinical position.
Alison L. Hannah, M.D. appointed Executive Vice President and Chief Medical Officer on July 1, 2026
Dr. Hannah resigned from the Board of Directors effective July 1, 2026; she had served on the Board since May 2021
Lisa Rojkjaer, M.D. ceased to be Executive Vice President and Chief Medical Officer and separated from the company effective June 25, 2026
Biogen said its second-quarter 2026 GAAP and non-GAAP results will include about $164 million in pre-tax acquired in-process R&D, upfront and milestone expense, reducing diluted earnings per share by about $0.95. It also expects third-quarter charges of $290 million to $320 million, or $1.75 to $1.95 per diluted share, tied to potential milestones and transactions that have not yet closed. Shareholders face lower reported earnings in both quarters, and the second-quarter figures are preliminary.
Q2 2026 acquired IPR&D, upfront and milestone expense: about $164 million pre-tax, about $0.95 per diluted share
Q3 2026 expected expense: $290 million to $320 million, about $1.75 to $1.95 per diluted share
Q3 estimate relates to potential milestones and transactions that have not yet closed
Quarter ended June 30, 2026 results have not been finalized and may differ from these estimates
World Acceptance Corporation entered into an accordion increase under its revolving credit agreement on June 29, 2026, adding a $15.0 million commitment from Investar Bank, National Association. Aggregate lender commitments rose from $640.0 million to $655.0 million, giving the company more borrowing capacity under a routine financing arrangement.
Accordion increase of $15.0 million from Investar Bank, National Association, dated June 29, 2026
Aggregate commitments under the revolving credit agreement rose from $640.0 million to $655.0 million
Company agreed to pay an upfront fee of 0.15% of the Increasing Lender's commitment and issued a $15.0 million revolving credit note
Zumiez Inc. said its Chief Financial Officer, Christopher C. Work, gave notice on June 30, 2026 that he will step down. Mr. Work will remain in the role and help with the transition until a successor is appointed, and the company has hired an executive search firm to find a new CFO.
CFO Christopher C. Work gave notice of his decision to step down on June 30, 2026.
Mr. Work served the company for 19 years and will continue as CFO during the transition.
The company has started a search for a new CFO and engaged a leading executive search firm.
Crescent Capital BDC, Inc. exercised its option on June 29, 2026 to prepay $50.0 million of 7.54% senior unsecured notes that were due July 28, 2026. The company paid about $51.6 million, covering the principal and accrued, unpaid interest through the prepayment date. The filing says none of the notes remain outstanding, which removes that debt before its scheduled maturity.
Prepaid principal: $50.0 million of 7.54% senior unsecured notes
Original maturity date: July 28, 2026
Total amount paid: about $51.6 million, including accrued and unpaid interest
Prepayment date: June 29, 2026; notes now fully repaid
At its June 25, 2026 annual meeting, Box stockholders approved an amendment adding 7,200,000 Class A shares to the 2015 Equity Incentive Plan, re-elected three Class III directors, approved executive pay on an advisory basis, and ratified Ernst & Young LLP as auditor. The plan increase expands the pool of shares available for equity awards, which can dilute existing shareholders.
Plan amendment adds 7,200,000 Class A common shares to the 2015 Plan; the vote was 75,004,119 for and 46,994,892 against
Sue Barsamian, Jack Lazar and Steve Murphy elected as Class III directors, serving until the 2029 annual meeting
Holders representing 83.30% of voting power attended, constituting a quorum
Ernst & Young LLP ratified as auditor for the fiscal year ending January 31, 2027
Scotts Miracle-Gro's board named Nathan E. Baxter president and chief executive officer, effective June 26, 2026, and elected him to the board. Jim Hagedorn, CEO since 2001 and chairman since 2003, resigned from the board, and Lead Independent Director Peter Shumlin was elected chairman. The company reaffirmed its fiscal 2026 guidance in the same announcement.
Nathan E. (Nate) Baxter, 53, has been president and chief operating officer since November 2024; his base salary is $1,100,000 with a 150% target incentive.
Baxter will receive a true-up restricted stock unit grant with a grant date value of $2,000,000, and an annual long-term incentive target of $5,250,000 for the upcoming fiscal year.
Hagedorn's separation payment is $17,400,000, reduced by the value of his accrued pension benefit and paid over twelve months, plus $500,000 in aircraft-related services and $150,000 for administrative support.
The company reaffirmed fiscal 2026 guidance, including non-GAAP adjusted net income per share from continuing operations of $4.15 to $4.35.
Mativ Holdings expanded its board from 6 to 7 members and appointed Bruce Hausmann, currently Vice President and Chief Financial Officer of Interface, Inc., as a Class I director effective July 1, 2026. He also joined the Audit Committee and was determined to be an audit committee financial expert, which adds finance and M&A experience to board oversight.
Hausmann, age 56, has been Interface's CFO since April 2017 and has over 25 years of finance experience
Term expires at the 2029 Annual Meeting of Stockholders; appointed to Audit Committee effective July 1, 2026
On June 17, 2026, the Compensation Committee approved raising the annual stock-based retainer for non-employee directors to $150,000
Flexible Solutions International signed an at-the-market sales agreement with Bancroft Capital on June 30, 2026, allowing it to sell common stock worth up to $18.5 million through the agent. The company will pay Bancroft a 3% cash fee on gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter, so new shares could dilute existing holders.
Agreement dated June 30, 2026, with Bancroft Capital, LLC as sales agent for up to $18,500,000 of common stock
Shares sold under effective Form S-3 (Registration No. 333-293705), declared effective March 5, 2026
Cash fee of 3% of gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter
Choice Hotels International appointed Ali Keshavarz as a director effective June 26, 2026, expanding the board to twelve members. Keshavarz is President and Chief Data & Analytics Officer of CVS Health, and the company says his AI and analytics expertise will support its long-term growth strategy.
Ali Keshavarz appointed director effective June 26, 2026, with a term expiring at the 2027 Annual Meeting of Shareholders
Board size now twelve directors; committee assignments have not been determined
Keshavarz previously served as Chief Analytics Officer for Aetna and CVS Caremark and spent more than a decade at McKinsey
Director compensation is consistent with other non-employee directors, per the April 22, 2026 proxy statement
Tortoise Energy Infrastructure Corp. said director Alexandra Herger's resignation took effect July 1, 2026, and its board appointed John Maxwell, age 63, to succeed her. Maxwell will also serve on the Nominating and Governance Committee and has been nominated for a full three-year term as a Class I director at the 2026 Annual Meeting.
Alexandra Herger resigned as a director effective July 1, 2026, as previously disclosed in an April 24, 2026 letter.
John Maxwell, age 63, was appointed director effective July 1, 2026, and joins the Nominating and Governance Committee.
Maxwell was nominated for a three-year Class I director term at the 2026 Annual Meeting.
Maxwell previously was Lead Portfolio Manager at Delaware Ivy Investments (2006 to 2021) and retired in 2021.
REX American Resources disclosed new employment agreements with Executive Chairman Stuart A. Rose, CEO Zafar A. Rizvi, and CFO Douglas L. Bruggeman, executed June 29, 2026 and effective February 1, 2026. The agreements raise maximum annual bonuses and maximum severance-related bonuses for all three executives, which increases potential compensation costs for shareholders.
Rizvi's annual maximum bonus rises from $5,000,000 to $12,000,000; his maximum termination bonus rises from $6,000,000 to $12,000,000.
Rose's annual maximum bonus rises from $2,500,000 to $4,000,000; his maximum termination bonus rises from $3,000,000 to $5,000,000.
Bruggeman's annual maximum bonus rises from $2,500,000 to $4,000,000; his maximum termination bonus rises from $3,000,000 to $5,000,000.
Base salaries are $225,000 for Rose, $275,000 for Rizvi and $300,000 for Bruggeman; the agreements supersede prior agreements.
Prologis, Inc. appointed Alfred F. Kelly, Jr. as a director on June 29, 2026, and announced it in a July 1, 2026 press release. The board determined Kelly is independent under NYSE and SEC rules, and he will join the Board Governance and Nomination Committee. The filing does not describe any financial results or changes to company operations.
Kelly was appointed to the board on June 29, 2026 and will join the Board Governance and Nomination Committee.
Kelly was chief executive officer of Visa Inc. from 2016 to 2023 and chairman of Visa's board from 2019.
He will receive compensation under Prologis' non-employee director program, as described in its 2026 proxy statement filed March 19, 2026.
CEO Dan Letter said Kelly's experience in technology, risk and global markets will be a valuable addition to the board.
Belden Inc. completed its acquisition of RUCKUS Networks from Vistance Networks on July 1, 2026, paying approximately $1.87 billion in cash, net of cash acquired and subject to post-closing adjustments. The purchase was funded in part by a $1,850.0 million senior secured term loan from a syndicate led by JPMorgan Chase Bank, N.A., which adds debt and limits the company's ability to incur more indebtedness and pay dividends.
Cash paid of approximately $1.87 billion, net of cash acquired, subject to customary post-closing adjustments
$1,850.0 million senior secured term loan, interest at term SOFR plus 2.25% or base rate plus 1.25%, maturing July 1, 2033
Loan amortizes 0.25% per quarter and is secured by substantially all assets of the company and guarantors
Financial statements and pro forma information to be filed under Form 8-K/A within 71 calendar days after the filing deadline
Omnicell appointed Nnamdi Njoku as President effective July 1, 2026, while he keeps his role as Chief Operating Officer. Randall Lipps stepped down as President but continues as Chief Executive Officer and Chairman, and Njoku will report to him. The filing describes this as a change in how Omnicell's top leadership duties are divided, with Njoku focused on long-term growth strategy and operational execution.
Njoku was appointed President effective July 1, 2026, and remains Chief Operating Officer; he had been COO since October 2024
Lipps stepped down as President; he remains CEO and Chairman with no compensation changes tied to the transition
Board approved a one-time restricted stock unit award with a target grant date value of approximately $500,000; one-third vests after one year, the rest in equal amounts at two and three years
Njoku's 2026 base salary is unchanged at $661,000, with a target cash bonus of 100% of base salary
Casella Waste Systems appointed Damian A. Ribar as executive vice president and chief operating officer, with employment expected to start July 20, 2026. He previously served as a division vice president at Waste Connections, most recently in North Florida, from August 2025 until July 2026.
Appointment approved by the Board on June 26, 2026; Ribar accepted the offer letter on June 27, 2026
Base salary of $500,000, with a cash bonus of up to 85% of base salary
Expected annual equity awards: restricted stock units with a $200,000 grant date value and performance stock units with a $600,000 grant date value
One-time option grant for 25,000 Class A shares, granted after second quarter 2026 earnings are announced
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.